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Summary 
ONE hundred and fifty-eight cases of hepatitis B have been detected among Dublin drug-
abusers from January to August 1981 during an epidemic which originated in 1980 and still 
continues. The mean age was 21 years and the male/female susceptibility to hepatitis B was 
the same. An unusually high proportion (29%) of a sample of 50 tested had the hepatitis B 
associated delta antigen in their serum and confirms that the delta agent is probably common 
in drug addicts and not confined to Italy. 
Introduction 
 It is now well documented that hepatitis B is frequent among drug addicts, since those 
who use drugs intravenously regularly share syringes and needles (Grady e/ al, 1972; Sutnick 
et at, 1971; Alter, 1958; Altshul et al, 1952; Steigman et at, 1950; Blanck et al, 1979). In two 
studies (Sutnick et al, 1971; Cherubin and Hargrove, 1970) asymptomatic heroin users had an 
increased incidence of HBsAg antigenaemia and in a study of U.S. soldiers returning from 
Vietnam there was a significant increase in HBsAg positivity in those abusing heroin by any 
method compared with non-drug-taking controls. There was also a significant increase in anti-
HBs positivity among those using heroin intravenously compared with those using heroin by 
smoking and sniffing (Blanck et al, 1979). 
 Hepatitis B markers among drug-abusers have been monitored by the Virus Reference 
Laboratory, University College Dublin, since 1970. Up to the beginning of 1980 the incidence 
of hepatitis B surface antigen (HBsAg) among drug-abusers has been low but increasing from 
an average of two cases per year between 1970-1974 to 10 cases per year between 1975 and 
1979, in proportion to a general increase in drug abuse. This paper reports an alarming 
increase in hepatitis B among drug-abusers in Dublin during 1981. 
 We also report the unusual finding of delta antigen in the serum of a significant number 
of abusers in this epidemic. The delta antigen, found in the liver of some patients with 
hepatitis B infection, has been shown to be associated with a transmissable agent (the delta 
agent) which co-infects with, and may be dependent on, hepatitis B virus (Editorial, Lancet, 
1982). 
Patients and Methods 
Patients 
 The patients in this report were principally those attending the Drug Advisory and 
Treatment Centre, or as in-patients with hepatitis, at The Charitable Infirmary, Dublin, during 
1980 and up to August 31st 1981. Drug-abusers with hepatitis admitted to other hospitals are 
also included. Two other groups of drug-abusers, one negative for all hepatitis B virus (HBV) 
markers and the other with antibody to the hepatitis B core antigen (anti-HBc) only were used 
as controls, totalling 105. 
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Serological tests for HBV markers 
Screening tests for HBsAg were carried out by radio-imunoassay (RIA, Abbott) using 
overnight incubation at 45°C, and for antibody to HBsAg (Anti-HBs) by immunodiffusion 
(ID) on concentrated sera (Shattock, 1974). 
 Patients positive for HBsAg were also tested for the hepatitis B ‘e’ antigen 
TABLE 
 
No. Male Female Ratio 
Mean 
age 
Duration of IV 
Drug-abuse 
(yrs.) 
Range 
(yrs.) 
HBsAg Positive 140 110 30 3.7:1 21.4 2.9 0.1 - 17 
Anti-HBs Positive 18 15 3 5:1 22.0 4.0 1 - 12 
TOTALS 158 125 33 3.8:1 21.7 3.5 0.1 - 17 
Outline data on 158 cases of HBV infection in drug-abusers detected from January to August 1981. 
(HBeAg) and antibody to it (Anti-HBe) by a semimicro ID in 0.7% agarose in barbitone 
buffer at Ph 8.6, with double filling of wells with serum samples concentrated a minimum of 
four-fold with polyacrylamide gel (“lyphogel”, Hawksley Ltd). 
Tests for anti-HBc IgG were carried out by RIA (Abbot ‘Corab’) or enzyme immunoassay 
(EIA, Abbott ‘Corezyme’) according to the manufacturers’ instructions. 
 For the purposes of this study drug-abusers were classified as having ‘acute’ HBV 
infection if they cleared their HBsAg within 4 months, had clinical and biochemical findings 
consistent with acute hepatitis and cleared HBeAg within 2 weeks of onset, and/or sero-
converted to anti-HBe positivity. 
 Tests for delta antigen and antibody were kindly carried out by Dr. M. Rizzetto 
(Ospedale Maggiore, Turin) using an RIA technique developed by him, on serum samples 
pre-treated with the non-ionic detergent Nonidet P40 (Rizzetto et al, 1975). 
Results 
 The figure shows the incidence of HBsAg and anti-HBs positives among drug-abusers 
tested since 1970. From January to August 31st, 1981, 158 cases of HBV infection among 
drug-abusers have been detected compared with 37 for the whole of 1980. The Table shows 
the data for age, sex ratio and mean duration of intravenous drug abuse. The male to female 
ratio was nearly four to one which exactly reflects the male/ female ratio among the drug-
abuser population as a whole in Dublin. The average age was approximately 21 years, ranging 
from 14-34 years. Again this did not differ from the average age of the abuser group as a 
whole. The duration of intravenous drug abuse varied from one month to 17 years. However, 
in many cases the duration of intravenous drug abuse was not disclosed or not asked. Those 
with anti-HBs were, on average, using heroin intravenously longer but not significantly so. 
Six females and one male included in this study denied intravenous drug abuse but had sexual 
contact with intravenous drug-abusers and are fully reported elsewhere (Kelly et al, 1982). 
 A control group of 105 HBsAg and anti-HBs negative drug-abusers were examined for 
anti-HBc to determine the proportion in previous contact with hepatitis B. Forty-six per cent 
were positive. 
 Fifty HBsAg positive drug-abusers from this epidemic have been tested for the delta 
antigen and antibody. Surprisingly, 14 (29%) of these had serum delta antigen. One had anti-
delta and one had both delta antigen and antibody. Four anti-HBs positive drug-abusers were 
also tested and one had delta 
 antigenaemia. This patient had acute hepatitis which was serologically negative for hepatitis 
A IgM antibody and his anti-HBs titre remained unchanged before and after the acute 
episode. Delta antigen and antibody were not found in any of 19 HBsAg positive non-drug-
abusing patients with acute hepatitis tested. 
Discussion 
 The epidemic appears to have originated during the Summer of 1980, the first sharp 
rise in hepatitis cases occurring in November, approximately 6 months following the increase 
in numbers using heroin by smoking, snorting and sniffing. 
 Many of these changed to intravenous use of heroin approximately 3 months before the 
rise. The reason for the unexpected rise and fall of incidence of hepatitis B cases in 
consecutive months in the Figure is not known but suggests periodic transfer of hepatitis B 
from one group of abusers to the next. Although there has been no diminution in the numbers 
of new heroin users the epidemic is showing signs of declining or levelling off (October 
1981). It appears that new groups are not intermixing with previous groups. 
 The incidence of hepatitis B among males and females was the same as the male to 
female drug-abuser ratio and strongly suggests that male/female susceptibility to HBV 
infection is the same among drug-abusers. 
 The abusers who denied intravenous use of drugs admitted intimate association with 
intravenous drug-abusers; these are regarded as secondary cases occurring as a result of 
transmission by close sexual contact or by other inapparent parenteral routes (Frosner et al, 
1975; Heingst, 1973 and Heathcote and Sherlock, 1973). Follow-up has revealed further cases 
of hepatitis B occurring among non-drug-abusing contacts of drug-abusers arising from this 
epidemic (Kelly et al, 1982). 
 The reasons for this dramatic increase in hepatitis B in Dublin drug-abusers are thought 
to be principally the increased availability of heroin and the increased use of this drug 
intravenously by a relatively large number of young adults a few months before the onset of 
the epidemic. Also anti-HBc tests on current and past attenders at the clinic showed that 54% 
of abusers had not encountered hepatitis B previously, indicating a large non-immune 
reservoir. However, increased referral of patients with hepatitis to the Clinic, including self-
referral among the abuser groups, coupled with increased surveillance, have probably 
contributed to the numbers of hepatitis B cases detected. 
 The delta antigen has been found in the liver of some patients with HBV infection in 
the south of Italy. Chronic carriers of HBsAg with intrahepatic delta antigen have high litres 
of anti-delta but the presence of serum delta antigen has been rarely reported. To date delta 
antigen or antibody has not been reported in the absence of evidence of HBV infection so that 
it appears that the delta agent may be dependent on HBV (Rizzetto, Purcell et al, 1980). Anti-
delta has been reported more common in haemophiliacs, drug-abusers and other groups with 
multiple parenteral exposure (Pera et al, 1981 and Rizzetto, Purcell et al, 1980). 
 Our finding of 29% of 50 HBsAg positive drug-abusers with delta antigenaemia is 
unusually and unexpected since delta antigenaemia was shown to be very transient in 
chimpanzee transmission experiments (Rizzetto, Canese et al, 1980). It also confirms that the 
delta agent is not confined to localities such as Italy (Raimondo et al, 1982). Our case of delta 
antigenaemia in the anti-HBs positive abuser with acute hepatitis is of great interest since it 
suggests independent delta infection. These and other cases are part of an ongoing study to 
see if the presence of delta is modifying the short and long-term outcome of HBV infection 
and are the subject of a separate report (Shattock et al, 1982). The existence of underlying 
chronic liver disease attributable to non-A, non-B hepatitis in a number of patients from this 
epidemic has also become evident and is reported elsewhere (Shattock et al, 1981; Shattock, 
1982). 
 We would like to thank Dr. E. O’Connor and Dr. S. O’Dea of Cherry Orchard Hospital, 
and Prof. D. Weir of Sir Patrick Dun’s Hospital, for allowing their patients to be included. 
FOOTNOTE 
 Since August 1981 the numbers of hepatitis B cases among drug-abusers has remained 
at a high level, averaging between 10 and 15 new cases per month. 
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